Values First Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,324
Closed -$1.17M 257
2024
Q3
$1.17M Buy
2,324
+189
+9% +$91.8K 0.64% 49
2024
Q2
$1.04M Sell
2,135
-276
-11% -$139K 0.62% 53
2024
Q1
$1.3M Sell
2,411
-204
-8% -$111K 0.76% 40
2023
Q4
$1.45M Buy
2,615
+394
+18% +$185K 0.88% 37
2023
Q3
$971K Buy
2,221
+22
+1% +$11K 0.63% 47
2023
Q2
$1.1M Buy
2,199
+15
+0.7% +$7.19K 0.67% 45
2023
Q1
$1.09M Sell
2,184
-770
-26% -$368K 0.7% 43
2022
Q4
$1.21M Buy
2,954
+372
+14% +$144K 0.84% 39
2022
Q3
$841K Buy
2,582
+364
+16% +$134K 0.6% 55
2022
Q2
$778K Buy
2,218
+420
+23% +$171K 0.55% 57
2022
Q1
$983K Buy
1,798
+183
+11% +$96.3K 0.62% 50
2021
Q4
$1.06M Buy
1,615
+254
+19% +$159K 0.63% 54
2021
Q3
$847K Sell
1,361
-213
-14% -$143K 0.55% 58
2021
Q2
$994K Buy
1,574
+278
+21% +$154K 0.67% 51
2021
Q1
$634K Buy
1,296
+40
+3% +$20K 0.47% 77
2020
Q4
$628K Sell
1,256
-64
-5% -$28.6K 0.5% 68
2020
Q3
$519K Buy
1,320
+183
+16% +$67.7K 0.48% 72
2020
Q2
$375K Sell
1,137
-99
-8% -$28.7K 0.37% 90
2020
Q1
$299K Buy
1,236
+276
+29% +$72K 0.36% 85
2019
Q4
$251K Buy
+960
New +$253K 0.24% 110

Other funds holding IDXX

Values First Advisors's IDXX Position: Q4 2024 in Review

Values First Advisors sold out of Idexx Laboratories (IDXX) in Q4 2024, closing a stake of 2,324 shares — an estimated $1.17M sold.

Values First Advisors first reported a position in IDXX in Q4 2019 and held it in 20 quarters. The position peaked at $1.45M in Q4 2023. 1,123 funds tracked by Wall St. Rank hold IDXX as of Q4 2024.

  • Values First Advisors reported no remaining Idexx Laboratories position as of Q4 2024 after selling out during the quarter.
  • Values First Advisors sold 2,324 Idexx Laboratories shares in Q4 2024, an estimated $1.17M.
  • Values First Advisors first reported a position in Idexx Laboratories in Q4 2019 and held it in 20 quarters.
  • Values First Advisors's Idexx Laboratories position peaked at $1.45M in Q4 2023.
  • 1,123 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2024.

Based on Values First Advisors's 13F filing for Q4 2024, filed 29 Jan 2025.